The Amyloidosis Channel is supported with funding from Prothena (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ISA 2024 | The value of close collaboration between cardiologists, hematologists & other MDTs in amyloidosis
In this video, Daniel Judge, MD, Medical University of South Carolina, Charleston, SC, briefly explains the importance of close collaboration between cardiologists, hematologists, and a wider multidisciplinary team (MDT) when treating patients with amyloidosis. This interview took place at the XIX International Symposium on Amyloidosis (ISA) in Rochester, MN.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Consultancy fees: BridgeBio
